Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.734
4.11 %
$ 4.07 M
Market Cap
-0.27
P/E
BALANCE SHEET
27.9 M
ASSETS
23.1 M
LIABILITIES
4.79 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Biofrontera Inc.
| Current Assets | 23.1 M |
| Cash & Short-Term Investments | 1.42 M |
| Receivables | 5.16 M |
| Other Current Assets | 16.5 M |
| Non-Current Assets | 4.86 M |
| Long-Term Investments | 0 |
| PP&E | 1.75 M |
| Other Non-Current Assets | 3.11 M |
| Current Liabilities | 18.1 M |
| Accounts Payable | 9.01 M |
| Short-Term Debt | 5.29 M |
| Other Current Liabilities | 3.8 M |
| Non-Current Liabilities | 5.05 M |
| Long-Term Debt | 804 K |
| Other Non-Current Liabilities | 4.25 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 1.3 | 17.2 | 24.5 | 8.1 | 7.3 |
| Short Term Investments | 78 K | 10.5 | 0 | 0 | 0 |
| Receivables | 5.2 | 7.4 | 3.8 | 3.3 | 4.8 |
| Inventory | 10.9 | 7.2 | 4.5 | 7.1 | 10.5 |
| Other Current Assets | 5.6 | 0.8 | 13.6 | 1.1 | 0.9 |
| Total Current Assets | 23.1 | 43.1 | 46.4 | 19.6 | 23.5 |
| PP&E | 1.7 | 1.6 | 0.3 | 0.4 | 0.5 |
| Intangible Assets | 2.6 | 3.0 | 3.5 | 3.9 | 4.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 2.8 | 2.8 | 0 | 0 |
| Other Long Term Assets | 0.5 | 3.1 | 3.1 | 0.3 | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 27.9 | 50.9 | 53.2 | 24.1 | 28.8 |
| LIABILITIES | |||||
| Accounts Payable | 9.0 | 1.3 | 0.7 | 1.5 | 7.2 |
| Short Term Debt | 5.3 | 1.0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.8 | 11.7 | 9.9 | 2.9 | 4.5 |
| Total Current Liabilities | 18.1 | 20.9 | 13.8 | 4.4 | 11.7 |
| Long Term Debt | 0.8 | 0.8 | 0 | 0 | 38.2 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | (8.9) |
| Other Liabilities | 4.2 | 2.9 | 18.5 | 62 K | 58 K |
| Total Liabilities | 23.1 | 27.0 | 41.9 | 18.3 | 58.9 |
| EQUITY | |||||
| Common Stock | 2 K | 27 K | 17 K | 8 K | 0 |
| Retained Earnings | (99.7) | (79.5) | (78.9) | (41.2) | (30.2) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 4.8 | 23.9 | 11.3 | 5.8 | (30.2) |
| Total Liabilities and Equity | 27.9 | 50.9 | 53.2 | 24.1 | 28.8 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 1.5 | 1.1 | 0.9 | 0.6 | 0.6 |